Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
30
pubmed:dateCreated
2010-8-20
pubmed:abstractText
Site-specific delivery of drugs while minimizing unwanted distribution has been one of the pursued goals in cancer therapy. In this endeavor, we have developed targeted polymeric nanoparticles called amphiphilic urethane acrylate nonionomer (UAN) for encapsulation of diverse water-insoluble drugs and diagnostic agents, as well as for simple and reproducible surface conjugation of targeting ligands. Using monoclonal antibodies or lymphocyte function-associated antigen-1 (LFA-1) I domain engineered for varying affinities to intercellular adhesion molecule (ICAM)-1, we were able to deliver UAN nanoparticles to human cancer cells with the efficiency dependent on the strength of the molecular interactions and the degree of ICAM-1 expression on cell surface. Compared to non-specific uptake of free drugs, targeted delivery of UAN nanoparticles carrying equal amount of drugs produced more potent cytotoxicity. Notably, without the targeting ligands attached, UAN nanoparticles were largely precluded from non-specific uptake by the cells, resulting in much lower toxicity. The versatility of our UAN nanoparticles in both payload encapsulation and presentation of targeting ligands may facilitate developing a robust platform for evaluating various combinations of cancer drugs and molecular interactions toward developing effective cancer therapy formulations.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1878-5905
pubmed:author
pubmed:copyrightInfo
Copyright 2010 Elsevier Ltd. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
7766-75
pubmed:dateRevised
2011-10-3
pubmed:meshHeading
pubmed-meshheading:20667589-Animals, pubmed-meshheading:20667589-Antineoplastic Agents, pubmed-meshheading:20667589-Biocompatible Materials, pubmed-meshheading:20667589-Drug Carriers, pubmed-meshheading:20667589-Drug Compounding, pubmed-meshheading:20667589-Drug Delivery Systems, pubmed-meshheading:20667589-HeLa Cells, pubmed-meshheading:20667589-Humans, pubmed-meshheading:20667589-Intercellular Adhesion Molecule-1, pubmed-meshheading:20667589-Lymphocyte Function-Associated Antigen-1, pubmed-meshheading:20667589-Materials Testing, pubmed-meshheading:20667589-Models, Molecular, pubmed-meshheading:20667589-Molecular Structure, pubmed-meshheading:20667589-Nanoparticles, pubmed-meshheading:20667589-Neoplasms, pubmed-meshheading:20667589-Polymers, pubmed-meshheading:20667589-Protein Conformation, pubmed-meshheading:20667589-Triterpenes
pubmed:year
2010
pubmed:articleTitle
Self-assembled nanoplatform for targeted delivery of chemotherapy agents via affinity-regulated molecular interactions.
pubmed:affiliation
Department of Biomedical Engineering, Cornell University, Ithaca, NY 14853, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Evaluation Studies, Research Support, N.I.H., Extramural